Clinical Trials Directory

Trials / Completed

CompletedNCT01556243

Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer

Impact of Breast Conservation Surgery on Surgical Outcomes and Cosmesis in Patients With Multiple Ipsilateral Breast Cancers (MIBC)

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
270 (actual)
Sponsor
Alliance for Clinical Trials in Oncology · Academic / Other
Sex
Female
Age
40 Years
Healthy volunteers
Not accepted

Summary

RATIONALE: Breast-conserving surgery is a less invasive type of surgery for breast cancer and may have fewer side effects and improve recovery. Radiation therapy uses high-energy x rays to kill tumor cells. Giving radiation therapy after surgery may kill any tumor cells that remain after surgery. PURPOSE: This phase II trial studies how well breast-conserving surgery and radiation therapy work in treating patients with multiple ipsilateral breast cancer

Detailed description

OBJECTIVES: Primary * To assess the local recurrence (LR) rate with breast-conservation in patients with multiple ipsilateral primary breast cancer (MIBC). Secondary * To examine the conversion rate to mastectomy secondary to persistent positive margins; poor cosmesis within the first year of attempting breast-conservation surgery (BCS) or inability to satisfy the radiation dose constraints on the boost to the lumpectomy bed of each site of disease. * To assess whether patients who did not undergo re-excision for close margins (\< 2 mm) have a higher local recurrence (LR) rate than patients for whom negative margins were achieved. * To assess patient's perception of cosmesis and incidence of breast lymphedema. * To assess incidence of breast lymphedema * To examine the type and severity of adverse effects of breast conserving surgery and radiation for women with multiple ipsilateral primary breast cancer (MIBC). * To examine the radiation-related side effects of whole-breast radiation with a boost to 1 large or \> 1 lumpectomy site. OUTLINE: This is a multicenter study. Patients undergo breast-conserving surgery (BCS) with all lesions resected to negative margins using 1 lumpectomy or 2-3 separate lumpectomy incisions at the discretion of the surgeon. Patients receive adjuvant chemotherapy and/or endocrine therapy at the discretion of the treating medical oncologist based on tumor characteristics.

Conditions

Interventions

TypeNameDescription
PROCEDUREtherapeutic conventional surgery
RADIATIONwhole breast irradiation

Timeline

Start date
2012-07-01
Primary completion
2022-06-01
Completion
2023-04-15
First posted
2012-03-16
Last updated
2023-11-30
Results posted
2023-11-30

Locations

350 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01556243. Inclusion in this directory is not an endorsement.